Metformini Hydrochloridum Lnventla Healthcare B.V.

Metformin Hydrochloride, the active ingredient in Metformini Hydrochloridum Lnventla Healthcare B.V., is a biguanide presented as an oral tablet for oral use. It helps lower blood glucose in adults with type 2 diabetes mellitus.

GNH USA supplies Metformini Hydrochloridum Lnventla Healthcare B.V. as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Metformin Hydrochloride is used to manage hyperglycaemia in the type 2 diabetes mellitus pathway. - Type 2 diabetes mellitus: improves glycaemic control by lowering fasting and post‑prandial blood glucose levels. - Prediabetes (off‑label): may delay progression to overt diabetes when used under medical supervision. - Polycystic ovary syndrome (off‑label): can improve insulin resistance and menstrual regularity.

Metformin Hydrochloride is associated with a range of adverse reactions.

Common Side Effects: - Nausea: mild to moderate gastrointestinal upset. - Diarrhoea: frequent loose stools, especially at treatment initiation. - Abdominal discomfort: cramping or bloating. - Metallic taste: transient alteration in taste perception. - Weight loss: modest reduction in body weight. - Vitamin B12 deficiency: decreased absorption over long‑term use.

Serious or Rare Side Effects: - Lactic acidosis: rare but potentially fatal metabolic acidosis. - Severe skin reactions: such as Stevens‑Johnson syndrome. - Hepatotoxicity: liver enzyme elevations. - Hypoglycaemia: when combined with insulin or secretagogues. - Pancreatitis: inflammation of the pancreas. - Anemia: due to reduced red blood cell production.

Metformin Hydrochloride requires careful monitoring and patient education. - Renal function: assess creatinine clearance before initiation and periodically thereafter. - Hepatic impairment: avoid in patients with significant liver disease. - Contraindication: do not use in patients with severe renal insufficiency (eGFR <30 mL/min/1.73 m²). - Alcohol consumption: limit intake to reduce risk of lactic acidosis. - Elderly patients: start at lower doses and titrate slowly. - Store at room temperature: keep in the original container, protect from moisture and heat.

Metformin Hydrochloride can interact with several medicines, requiring vigilance.

Major Interactions (Avoid): - Iodinated contrast agents: may precipitate acute renal failure and increase lactic acidosis risk. - Cimetidine: can raise metformin plasma concentrations. - Alcohol: potentiates risk of lactic acidosis.

Moderate Interactions (Monitor Closely): - Beta‑blockers: may mask hypoglycaemia symptoms. - Diuretics: can affect renal clearance of metformin. - ACE inhibitors/ARBs: monitor renal function and potassium levels. - Oral contraceptives: may slightly increase metformin levels. - Anticoagulants (e.g., warfarin): monitor INR as metformin may alter INR stability.